Steris plc - Analyst consensus and long-term growth profile
20.06.2026 - 18:12:19 | ad-hoc-news.de
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 16:11 UTC. Details in the imprint.
Steris plc (IE00BFY8C754) is a US-listed medical equipment company specializing in infection prevention and sterilization solutions across hospitals and life sciences customers. With no fresh market-moving news from primary sources today, the focus shifts to analyst expectations and Steris’s long-term growth drivers based on recent public data.
All news and data on Steris plc stock
Key corporate releases, analyst commentary and price data for Steris plc stock are collected on the topic page and the company’s own investor-relations site.
What recent data show
Steris stock trades on the New York Stock Exchange under the ticker STE and is classified in the healthcare equipment and supplies industry. Recent valuation snapshots place the company’s market capitalization close to $20 billion, confirming its status as a large-cap healthcare name.
Based on aggregated valuation data, Steris currently trades at a price-to-earnings ratio in the mid-20s, implying a premium to many diversified industrials but broadly in line with higher-quality medical equipment peers focused on recurring revenue and specialized niches.
Analyst and ownership picture
Data from institutional-holding overviews indicate that Steris shares are predominantly held by large asset managers, with one source citing institutional ownership around three-quarters of the free float and a top holder with a stake above 6%. This supports the view of Steris as an established core holding in many healthcare portfolios.
Consensus services and valuation platforms describe a generally constructive stance on Steris, with expectations for continued revenue and earnings growth supported by aging populations, surgical procedure volumes and rising infection-prevention standards worldwide. Analysts tend to highlight the combination of equipment sales and service contracts as a key support for predictable cash flows.
How Steris makes its money
Steris generates most of its revenue from infection prevention, decontamination and surgical support solutions for healthcare, pharmaceutical and medical-device clients. This includes sterilizers, washer disinfectors, operating-room tables and lights, consumables, testing services and outsourced sterilization capacity.
According to the company’s profile, Steris operates across several segments serving hospitals, ambulatory surgery centers and life-science manufacturers. Many offerings are embedded deeply in customers’ clinical workflows, which tends to support high switching costs and multi-year service relationships.
Long-term growth drivers
Structural drivers for Steris include demographic trends, such as aging populations that require more surgical procedures, and stricter regulatory requirements around infection control in hospitals and pharmaceutical production. These tailwinds underpin demand for sterilization systems and related services over long horizons.
In addition, outsourcing of sterilization and decontamination to specialized providers remains a multi-year theme in both healthcare and life sciences. Steris’s installed base and global service network position the company to capture incremental volume as customers consolidate suppliers and elevate compliance standards.
The product behind the stock
Among Steris’s representative offerings are low-temperature hydrogen peroxide sterilization systems used for heat-sensitive medical instruments. These devices, together with compatible consumables and service contracts, illustrate the company’s strategy of combining specialized equipment with recurring revenue from maintenance and materials.
Where the stock trades today
The shares of Steris plc (IE00BFY8C754) trade on the New York Stock Exchange under the ticker STE, with the latest available composite price data showing the stock around the low-$200 range in recent sessions in US dollars as of 06/20/2026, 16:00 UTC.
Key facts on Steris plc stock
- Company: Steris plc
- ISIN: IE00BFY8C754
- WKN: A14M9S
- Ticker: STE
- Venue: NYSE
- Price (as of 06/20/2026, 16:00 UTC): around 202.61 USD
- Market cap: about 19.9 billion USD (as of 06/20/2026)
- Sector / Industry: Health Care - Health Care Equipment & Supplies
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
